Baotou Dongbao Bio-Tech Co.,Ltd

SZSE:300239 Stock Report

Market Cap: CN¥2.7b

Baotou Dongbao Bio-TechLtd Balance Sheet Health

Financial Health criteria checks 5/6

Baotou Dongbao Bio-TechLtd has a total shareholder equity of CN¥1.9B and total debt of CN¥471.1M, which brings its debt-to-equity ratio to 24.3%. Its total assets and total liabilities are CN¥2.8B and CN¥887.9M respectively. Baotou Dongbao Bio-TechLtd's EBIT is CN¥117.9M making its interest coverage ratio -96.1. It has cash and short-term investments of CN¥797.4M.

Key information

24.3%

Debt to equity ratio

CN¥471.06m

Debt

Interest coverage ratio-96.1x
CashCN¥797.41m
EquityCN¥1.94b
Total liabilitiesCN¥887.89m
Total assetsCN¥2.82b

Recent financial health updates

No updates

Recent updates

Baotou Dongbao Bio-TechLtd's (SZSE:300239) Dividend Will Be Reduced To CN¥0.022

May 27
Baotou Dongbao Bio-TechLtd's (SZSE:300239) Dividend Will Be Reduced To CN¥0.022

Sentiment Still Eluding Baotou Dongbao Bio-Tech Co.,Ltd (SZSE:300239)

Feb 28
Sentiment Still Eluding Baotou Dongbao Bio-Tech Co.,Ltd (SZSE:300239)

Financial Position Analysis

Short Term Liabilities: 300239's short term assets (CN¥1.4B) exceed its short term liabilities (CN¥326.2M).

Long Term Liabilities: 300239's short term assets (CN¥1.4B) exceed its long term liabilities (CN¥561.6M).


Debt to Equity History and Analysis

Debt Level: 300239 has more cash than its total debt.

Reducing Debt: 300239's debt to equity ratio has increased from 5.1% to 24.3% over the past 5 years.

Debt Coverage: 300239's debt is well covered by operating cash flow (51.5%).

Interest Coverage: 300239 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies